TP73 and amyotrophic lateral sclerosis: When the clinical phenotype analysis was restricted to patients with ALS with only TP73 mutations, a distinct clinical profile emerges, with a considerably higher mean age at onset (61.5 ± 7.72 years), a shorter survival time (19.25 ± 10.01 months), and invariably limb onset.